Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ligand Pharmaceuticals - 33 Year Stock Price History | LGND

Historical daily share price chart and data for Ligand Pharmaceuticals since 1992 adjusted for splits and dividends. The latest closing stock price for Ligand Pharmaceuticals as of July 14, 2025 is 126.92.
  • The all-time high Ligand Pharmaceuticals stock closing price was 171.24 on September 28, 2018.
  • The Ligand Pharmaceuticals 52-week high stock price is 129.90, which is 2.3% above the current share price.
  • The Ligand Pharmaceuticals 52-week low stock price is 90.29, which is 28.9% below the current share price.
  • The average Ligand Pharmaceuticals stock price for the last 52 weeks is 109.48.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ligand Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 110.5161 108.4200 126.9200 96.6700 126.9200 18.45%
2024 92.0149 72.3100 129.9000 68.5300 107.1500 50.03%
2023 67.6952 66.0300 79.3300 49.5700 71.4200 6.92%
2022 63.2471 94.5477 94.5477 46.4878 66.8000 -30.67%
2021 86.7837 63.0505 134.6410 62.0836 96.3568 55.31%
2020 61.3582 65.3400 79.0518 39.5321 62.0399 -4.64%
2019 69.6699 85.4648 88.8771 53.8054 65.0593 -23.15%
2018 117.0843 86.4816 171.2350 80.0749 84.6538 -0.90%
2017 75.4381 63.9426 91.7280 62.6201 85.4211 34.76%
2016 67.9819 63.9239 86.4192 53.5184 63.3874 -6.28%
2015 54.0040 33.5184 69.7754 32.1522 67.6357 103.76%
2014 36.9259 32.1397 49.6444 26.4255 33.1940 1.16%
2013 23.1730 12.9258 36.1510 11.9526 32.8135 153.62%
2012 9.9529 7.4298 13.4311 7.1678 12.9382 74.72%
2011 7.1613 5.6082 9.9501 5.3961 7.4049 33.07%
2010 5.8453 7.4155 7.4155 4.7842 5.5646 -24.96%
2009 8.7186 9.2267 10.7644 5.6726 7.4155 -20.80%
2008 11.0055 16.6079 16.6079 4.3399 9.3633 -43.27%
2007 22.8008 27.9525 33.2816 13.3273 16.5054 -41.17%
2006 28.1130 29.4641 35.3569 20.3687 28.0550 -1.79%
2005 21.0533 28.6955 29.8484 12.1700 28.5673 -4.21%
2004 36.6444 38.2521 61.5415 20.1381 29.8228 -20.76%
2003 27.5471 14.0147 41.3010 9.5566 37.6372 173.56%
2002 29.5421 43.6837 51.2163 12.5799 13.7584 -70.00%
2001 30.8610 35.2288 48.6799 20.1125 45.8615 27.86%
2000 36.2779 35.5491 65.1733 25.2207 35.8693 8.74%
1999 25.0894 28.6634 35.7092 16.8137 32.9870 10.75%
1998 30.6537 32.6667 41.3138 14.7320 29.7844 -9.71%
1997 34.2790 39.3522 46.9184 23.3791 32.9870 -13.45%
1996 33.7549 26.5817 48.6799 26.2615 38.1112 38.37%
1995 20.1352 20.4968 28.1831 14.0915 27.5426 30.30%
1994 30.3309 30.7452 36.5099 16.0131 21.1373 -29.79%
1993 26.1919 31.3857 31.3857 22.4183 30.1046 11.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.449B $0.167B
Ligand, being a biotechnology company, focuses on developing/acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand's Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. Captisol is a well validated chemically modified cyclodextrin that is designed to improve safety and solubility, stability, and bioavailability or lessen the volatility, irritation, smell or taste of drugs. Ligand has merged with CyDex. By this, it added an antibody-generating platform, OmniAb, to the company's portfolio. Its other technology platforms include antigen discovery platform & protein expression platform. All these technologies have created a strong platform for Ligand to seek new licenses and partnerships. Ligand has partnership agreements with leading healthcare companies like Novartis, Amgen, Merck, Pfizer, Celgene, Gilead & Lilly, etc. The company continues to buy smaller companies to increase its technology platforms.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $222.488B 16.61
Amgen (AMGN) United States $159.715B 14.31
Gilead Sciences (GILD) United States $139.432B 14.48
Vertex Pharmaceuticals (VRTX) United States $121.298B 0.00
Bristol Myers Squibb (BMY) United States $96.341B 6.45
GSK (GSK) United Kingdom $78.393B 9.38
CSL (CSLLY) Australia $77.367B 0.00
Regeneron Pharmaceuticals (REGN) United States $61.604B 14.95
Alnylam Pharmaceuticals (ALNY) United States $41.170B 0.00
Argenex SE (ARGX) Netherlands $34.350B 93.55
BioNTech SE (BNTX) Germany $26.684B 0.00
Royalty Pharma (RPRX) United States $20.376B 8.61
Biogen (BIIB) United States $19.504B 8.41
Insmed (INSM) United States $19.330B 0.00
Illumina (ILMN) United States $15.597B 29.59
Genmab (GNMSF) Denmark $14.203B 14.52
Genmab (GMAB) Denmark $13.768B 15.44
Incyte (INCY) United States $13.546B 102.91
Moderna (MRNA) United States $12.712B 0.00
Exelixis (EXEL) United States $12.430B 21.10
BioMarin Pharmaceutical (BMRN) United States $11.167B 18.14
QIAGEN (QGEN) Netherlands $10.732B 20.88
Ascendis Pharma (ASND) Denmark $10.691B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $10.243B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.911B 0.00
Blueprint Medicines (BPMC) United States $8.354B 0.00
Bio-Techne Corp (TECH) United States $8.249B 30.77
Roivant Sciences (ROIV) United Kingdom $7.906B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.259B 0.00
Legend Biotech (LEGN) United States $7.248B 0.00
Revolution Medicines (RVMD) United States $7.147B 0.00
Halozyme Therapeutics (HALO) United States $7.104B 13.60
Bio-Rad Laboratories (BIO.B) United States $7.014B 24.41
Anbio Biotechnology (NNNN) Germany $6.858B 0.00
Repligen (RGEN) United States $6.817B 76.31
Jazz Pharmaceuticals (JAZZ) Ireland $6.743B 6.62
TG Therapeutics (TGTX) United States $6.179B 162.17
Guardant Health (GH) United States $6.166B 0.00
Nuvalent (NUVL) United States $6.074B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.672B 0.00
Axsome Therapeutics (AXSM) United States $5.531B 0.00
Telix Pharmaceuticals (TLX) Australia $5.269B 0.00
Alkermes (ALKS) Ireland $4.896B 13.14
CRISPR Therapeutics AG (CRSP) Switzerland $4.873B 0.00
Vaxcyte (PCVX) United States $4.693B 0.00
Cytokinetics (CYTK) United States $4.608B 0.00
Metsera (MTSR) United States $4.462B 0.00
ADMA Biologics Inc (ADMA) United States $4.460B 33.36
Krystal Biotech (KRYS) United States $4.347B 33.50
Akero Therapeutics (AKRO) United States $4.204B 0.00
Zealand Pharma (ZLDPF) Denmark $4.088B 0.00
Avidity Biosciences (RNA) United States $4.046B 0.00
PTC Therapeutics (PTCT) United States $3.920B 6.82
Arcellx (ACLX) United States $3.853B 0.00
Merus (MRUS) Netherlands $3.850B 0.00
Zai Lab (ZLAB) China $3.808B 0.00
Scholar Rock Holding (SRRK) United States $3.664B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.664B 32.19
Viking Therapeutics (VKTX) United States $3.552B 0.00
Protagonist Therapeutics (PTGX) United States $3.423B 73.64
MoonLake Immunotherapeutics (MLTX) Switzerland $3.256B 0.00
Immunovant (IMVT) United States $3.180B 0.00
Ascentage Pharma Group - (AAPG) China $3.154B 0.00
Kymera Therapeutics (KYMR) United States $2.924B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.831B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.763B 0.00
Alvotech (ALVO) Luxembourg $2.683B 15.35
Mirum Pharmaceuticals (MIRM) United States $2.639B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.570B 0.00
ImmunityBio (IBRX) United States $2.560B 0.00
Apellis Pharmaceuticals (APLS) United States $2.502B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.502B 0.00
Agios Pharmaceuticals (AGIO) United States $2.272B 0.00
Twist Bioscience (TWST) United States $2.265B 0.00
Bavarian Nordic (BVNRY) Denmark $2.193B 11.59
Recursion Pharmaceuticals (RXRX) United States $2.146B 0.00
Denali Therapeutics (DNLI) United States $2.134B 0.00
Beam Therapeutics (BEAM) United States $2.129B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.102B 0.00
Belite Bio (BLTE) United States $2.024B 0.00
Vericel (VCEL) United States $2.005B 1327.33
Disc Medicine (IRON) United States $2.000B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.993B 13.25
IDEAYA Biosciences (IDYA) United States $1.978B 0.00
CG Oncology (CGON) United States $1.974B 0.00
NovoCure (NVCR) Jersey $1.942B 0.00
Amicus Therapeutics (FOLD) United States $1.921B 208.00
Arcutis Biotherapeutics (ARQT) United States $1.895B 0.00
Sarepta Therapeutics (SRPT) United States $1.890B 0.00
Certara (CERT) United States $1.807B 33.76
Apogee Therapeutics (APGE) United States $1.790B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.773B 0.00
Adaptive Biotechnologies (ADPT) United States $1.755B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.745B 0.00
89BIO (ETNB) United States $1.623B 0.00
Celldex Therapeutics (CLDX) United States $1.551B 0.00
Janux Therapeutics (JANX) United States $1.549B 0.00
Vera Therapeutics (VERA) United States $1.517B 0.00
Travere Therapeutics (TVTX) United States $1.502B 0.00
Edgewise Therapeutics (EWTX) United States $1.465B 0.00
Biohaven (BHVN) United States $1.449B 0.00
GRAIL (GRAL) United States $1.445B 0.00
Mesoblast (MESO) Australia $1.427B 0.00
ANI Pharmaceuticals (ANIP) United States $1.412B 14.55
Viridian Therapeutics (VRDN) United States $1.398B 0.00
Dynavax Technologies (DVAX) United States $1.290B 76.71
AbCellera Biologics (ABCL) Canada $1.265B 0.00
Cogent Biosciences (COGT) United States $1.263B 0.00
Pharvaris (PHVS) Netherlands $1.245B 0.00
Liquidia Technologies (LQDA) United States $1.238B 0.00
Intellia Therapeutics (NTLA) United States $1.238B 0.00
CureVac (CVAC) Germany $1.225B 5.93
MannKind (MNKD) United States $1.225B 25.19
WAVE Life Sciences (WVE) Singapore $1.220B 0.00
Novavax (NVAX) United States $1.129B 2.63
Structure Therapeutics (GPCR) United States $1.122B 0.00
Cidara Therapeutics (CDTX) United States $1.115B 0.00
Praxis Precision Medicines (PRAX) United States $1.092B 0.00
Pacira BioSciences (PCRX) United States $1.079B 10.27
Arcus Biosciences (RCUS) United States $1.022B 0.00
MiMedx (MDXG) United States $1.004B 24.29
Spyre Therapeutics (SYRE) United States $0.989B 0.00
Anavex Life Sciences (AVXL) United States $0.980B 0.00
Mineralys Therapeutics (MLYS) United States $0.979B 0.00
Nurix Therapeutics (NRIX) United States $0.970B 0.00
Sana Biotechnology (SANA) United States $0.952B 0.00
LENZ Therapeutics (LENZ) United States $0.949B 0.00
Zymeworks (ZYME) United States $0.930B 0.00
Oric Pharmaceuticals (ORIC) United States $0.925B 0.00
NeoGenomics (NEO) United States $0.924B 0.00
Niagen Bioscience (NAGE) United States $0.887B 125.11
Jyong Biotech (MENS) Taiwan $0.883B 0.00
Sionna Therapeutics (SION) United States $0.880B 0.00
Replimune (REPL) United States $0.870B 0.00
GH Research (GHRS) Ireland $0.858B 0.00
Geron (GERN) United States $0.853B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.848B 0.00
Trevi Therapeutics (TRVI) United States $0.822B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
UniQure (QURE) Netherlands $0.797B 0.00
Oculis Holding AG (OCS) Switzerland $0.793B 0.00
AnaptysBio (ANAB) United States $0.792B 0.00
BGM Group (BGM) China $0.786B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
CorMedix Inc (CRMD) United States $0.770B 51.64
Vir Biotechnology (VIR) United States $0.760B 0.00
ArriVent BioPharma (AVBP) United States $0.748B 0.00
Immatics (IMTX) Germany $0.743B 0.00
Immunome (IMNM) United States $0.740B 0.00
Nuvation Bio (NUVB) United States $0.728B 0.00
MeiraGTx Holdings (MGTX) United States $0.714B 0.00
Gyre Therapeutics (GYRE) United States $0.713B 190.25
Pharming Group (PHAR) Netherlands $0.709B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.705B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.702B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.700B 0.00
Maze Therapeutics (MAZE) United States $0.689B 0.00
Iovance Biotherapeutics (IOVA) United States $0.671B 0.00
Urogen Pharma (URGN) United States $0.668B 0.00
Tango Therapeutics (TNGX) United States $0.660B 0.00
Stoke Therapeutics (STOK) United States $0.658B 15.27
Prime Medicine (PRME) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Dianthus Therapeutics (DNTH) United States $0.644B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.633B 0.00
Upstream Bio (UPB) United States $0.631B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.629B 0.00
Arbutus Biopharma (ABUS) United States $0.621B 0.00
Keros Therapeutics (KROS) United States $0.592B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.582B 0.00
Tyra Biosciences (TYRA) United States $0.579B 0.00
Precigen (PGEN) United States $0.576B 0.00
Arvinas (ARVN) United States $0.574B 0.00
Sage Therapeutics (SAGE) United States $0.573B 0.00
Castle Biosciences (CSTL) United States $0.563B 38.24
Abivax SA (ABVX) France $0.560B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.560B 0.00
Bicara Therapeutics (BCAX) United States $0.555B 0.00
Kura Oncology (KURA) United States $0.550B 0.00
Zenas BioPharma (ZBIO) United States $0.536B 0.00
Septerna (SEPN) United States $0.535B 0.00
Rapport Therapeutics (RAPP) United States $0.534B 0.00
Opthea (OPT) Australia $0.525B 0.00
Celcuity (CELC) United States $0.521B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
ATyr Pharma (ATYR) United States $0.492B 0.00
Myriad Genetics (MYGN) United States $0.481B 0.00
Cullinan Therapeutics (CGEM) United States $0.464B 0.00
MBX Biosciences (MBX) United States $0.464B 0.00
Rezolute (RZLT) United States $0.455B 0.00
Fortrea Holdings (FTRE) United States $0.453B 12.52
Kamada (KMDA) Israel $0.447B 26.83
Terns Pharmaceuticals (TERN) United States $0.446B 0.00
REGENXBIO (RGNX) United States $0.436B 0.00
Tectonic Therapeutic (TECX) United States $0.432B 0.00
PureTech Health (PRTC) United States $0.428B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.427B 0.00
Fulcrum Therapeutics (FULC) United States $0.426B 0.00
Cytek Biosciences (CTKB) United States $0.424B 0.00
Solid Biosciences (SLDB) United States $0.424B 0.00
Erasca (ERAS) United States $0.414B 0.00
Compass Therapeutics (CMPX) United States $0.404B 0.00
Emergent Biosolutions (EBS) United States $0.396B 0.00
ITeos Therapeutics (ITOS) United States $0.396B 0.00
Eton Pharmaceuticals (ETON) United States $0.390B 0.00
Northwest Biotherapeutics (NWBO) United States $0.387B 0.00
Vigil Neuroscience (VIGL) United States $0.385B 0.00
Humacyte (HUMA) United States $0.383B 0.00
Astria Therapeutics (ATXS) United States $0.374B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.361B 0.00
Benitec Biopharma (BNTC) United States $0.348B 0.00
Gossamer Bio (GOSS) United States $0.348B 0.00
Prothena (PRTA) Ireland $0.346B 0.00
Absci (ABSI) United States $0.339B 0.00
Aura Biosciences (AURA) United States $0.339B 0.00
Cartesian Therapeutics (RNAC) United States $0.339B 0.00
Amarin (AMRN) Ireland $0.333B 0.00
Inhibrx Biosciences (INBX) United States $0.332B 0.20
ADC Therapeutics SA (ADCT) Switzerland $0.332B 0.00
XOMA Royalty (XOMA) United States $0.332B 0.00
Inventiva S.A (IVA) France $0.331B 0.00
Olema Pharmaceuticals (OLMA) United States $0.330B 0.00
Foghorn Therapeutics (FHTX) United States $0.328B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.326B 0.00
Ocugen (OCGN) United States $0.324B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.324B 65.75
Candel Therapeutics (CADL) United States $0.322B 0.00
Atea Pharmaceuticals (AVIR) United States $0.322B 0.00
Neurogene (NGNE) United States $0.317B 0.00
Palvella Therapeutics (PVLA) United States $0.305B 0.00
Abeona Therapeutics (ABEO) United States $0.303B 0.00
Lifecore Biomedical (LFCR) United States $0.303B 0.00
Vor Biopharma (VOR) $0.299B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.297B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.293B 0.00
Sagimet Biosciences (SGMT) United States $0.290B 0.00
Annexon (ANNX) United States $0.286B 0.00
Allogene Therapeutics (ALLO) United States $0.282B 0.00
DBV Technologies S.A (DBVT) France $0.280B 0.00
Tvardi Therapeutics (TVRD) United States $0.279B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.277B 0.00
Cardiff Oncology (CRDF) United States $0.275B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.273B 0.00
Kodiak Sciences (KOD) United States $0.273B 0.00
Verastem (VSTM) United States $0.273B 0.00
Monopar Therapeutics (MNPR) United States $0.267B 0.00
Aardvark Therapeutics (AARD) United States $0.263B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.261B 0.00
Entrada Therapeutics (TRDA) United States $0.258B 8.40
Codexis (CDXS) United States $0.254B 0.00
Crescent Biopharma (CBIO) United States $0.250B 0.00
Prima BioMed (IMMP) Australia $0.247B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
Adherex Technologies (FENC) United States $0.243B 0.00
Alpha Teknova (TKNO) United States $0.240B 0.00
Editas Medicine (EDIT) United States $0.239B 0.00
MaxCyte (MXCT) United States $0.238B 0.00
ScPharmaceuticals (SCPH) United States $0.237B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.234B 0.00
Semper Paratus Acquisition (TVGN) United States $0.232B 0.00
Design Therapeutics (DSGN) United States $0.227B 0.00
Adocia (ADOCY) France $0.216B 0.00
CARGO Therapeutics (CRGX) United States $0.212B 0.00
AC Immune (ACIU) Switzerland $0.209B 0.00
Neumora Therapeutics (NMRA) United States $0.205B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.201B 0.00
BioStem Technologies (BSEM) $0.201B 8.16
Ventyx Biosciences (VTYX) United States $0.200B 0.00
SELLAS Life Sciences (SLS) United States $0.198B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.197B 0.00
Alumis (ALMS) United States $0.196B 0.00
CytomX Therapeutics (CTMX) United States $0.193B 4.98
Kyverna Therapeutics (KYTX) United States $0.190B 0.00
Voyager Therapeutics (VYGR) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
Agenus (AGEN) United States $0.187B 0.00
Bright Minds Biosciences (DRUG) United States $0.181B 0.00
I-Mab (IMAB) United States $0.175B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.173B 0.00
DiaMedica Therapeutics (DMAC) United States $0.172B 0.00
Nuvectis Pharma (NVCT) United States $0.172B 0.00
Puma Biotechnology (PBYI) United States $0.171B 4.48
EnGene Holdings (ENGN) Canada $0.171B 0.00
C4 Therapeutics (CCCC) United States $0.169B 0.00
Alpha Cognition (ACOG) Canada $0.169B 0.00
Black Diamond Therapeutics (BDTX) United States $0.167B 49.00
Alector (ALEC) United States $0.167B 0.00
BioAge Labs (BIOA) United States $0.166B 0.00
Anika Therapeutics (ANIK) United States $0.165B 0.00
MiNK Therapeutics (INKT) United States $0.162B 0.00
Instil Bio (TIL) United States $0.161B 0.00
Caribou Biosciences (CRBU) United States $0.158B 0.00
Innate Pharma S.A (IPHA) France $0.157B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.152B 0.00
Immuneering (IMRX) United States $0.150B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.149B 0.00
Spero Therapeutics (SPRO) United States $0.148B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
Greenwich LifeSciences (GLSI) United States $0.145B 0.00
Rapt Therapeutics (RAPT) United States $0.144B 0.00
Elicio Therapeutics (ELTX) United States $0.144B 0.00
Molecular Partners AG (MOLN) Switzerland $0.143B 0.00
Compugen (CGEN) Israel $0.142B 0.00
Citius Oncology (CTOR) United States $0.139B 0.00
23andMe Holding (MEHCQ) United States $0.136B 0.00
Nkarta (NKTX) United States $0.134B 0.00
Fate Therapeutics (FATE) United States $0.131B 0.00
Seres Therapeutics (MCRB) United States $0.130B 0.00
Genelux (GNLX) United States $0.128B 0.00
Seer (SEER) United States $0.125B 0.00
Skye Bioscience (SKYE) United States $0.122B 0.00
Actuate Therapeutics (ACTU) United States $0.122B 0.00
Cellectis S.A (CLLS) France $0.120B 0.00
Sangamo Therapeutics (SGMO) United States $0.117B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.116B 0.00
BioHarvest Sciences (BHST) Canada $0.116B 0.00
Tenaya Therapeutics (TNYA) United States $0.116B 0.00
Oncolytics Biotech (ONCY) Canada $0.113B 0.00
IO Biotech (IOBT) Denmark $0.112B 0.00
Coherus Oncology (CHRS) United States $0.110B 0.00
HilleVax (HLVX) United States $0.109B 0.00
TScan Therapeutics (TCRX) United States $0.109B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
Coya Therapeutics (COYA) United States $0.103B 0.00
TuHURA Biosciences (HURA) United States $0.102B 0.00
Nautilus Biotechnology (NAUT) United States $0.099B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.098B 0.00
Whitehawk Therapeutics (WHWK) United States $0.097B 0.00
Contineum Therapeutics (CTNM) United States $0.097B 0.00
Climb Bio (CLYM) United States $0.096B 0.00
BeyondSpring (BYSI) United States $0.092B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.090B 0.00
Pliant Therapeutics (PLRX) United States $0.089B 0.00
Zura Bio (ZURA) United States $0.089B 0.00
XBiotech (XBIT) United States $0.088B 0.00
OKYO Pharma (OKYO) $0.087B 0.00
Invivyd (IVVD) United States $0.087B 0.00
Adagene (ADAG) China $0.086B 0.00
Cabaletta Bio (CABA) United States $0.086B 0.00
Elutia (ELUT) United States $0.084B 0.00
EXoZymes (EXOZ) United States $0.082B 0.00
Entera Bio (ENTX) Israel $0.082B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Quince Therapeutics (QNCX) United States $0.081B 0.00
Immix Biopharma (IMMX) United States $0.081B 0.00
Immunic (IMUX) United States $0.080B 0.00
TELA Bio (TELA) United States $0.079B 0.00
Connect Biopharma Holdings (CNTB) United States $0.078B 0.00
Oncobiologics (OTLK) United States $0.078B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.074B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.074B 0.00
Biomea Fusion (BMEA) United States $0.073B 0.00
Alto Neuroscience (ANRO) United States $0.073B 0.00
VistaGen Therapeutics (VTGN) United States $0.069B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
Repare Therapeutics (RPTX) Canada $0.067B 0.00
Opus Genetics (IRD) United States $0.066B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.066B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
Forte Biosciences (FBRX) United States $0.065B 0.00
Sutro Biopharma (STRO) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.064B 0.00
Adicet Bio (ACET) United States $0.064B 0.00
MediciNova (MNOV) United States $0.063B 0.00
CervoMed (CRVO) United States $0.062B 0.00
Earth Science Tech (ETST) United States $0.062B 0.00
Quantum Biopharma (QNTM) Canada $0.061B 0.00
InflaRx (IFRX) Germany $0.060B 0.00
ABVC BioPharma (ABVC) United States $0.060B 0.00
Applied Therapeutics (APLT) United States $0.060B 0.00
Cue Biopharma (CUE) United States $0.059B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
Werewolf Therapeutics (HOWL) United States $0.058B 0.00
Adverum Biotechnologies (ADVM) United States $0.057B 0.00
PDS Biotechnology (PDSB) United States $0.056B 0.00
Annovis Bio (ANVS) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Celularity (CELU) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Aligos Therapeutics (ALGS) United States $0.053B 0.00
Artiva Biotherapeutics (ARTV) United States $0.053B 0.00
Jasper Therapeutics (JSPR) United States $0.052B 0.00
ZIVO Bioscience (ZIVO) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.051B 0.00
Senti Biosciences (SNTI) United States $0.051B 0.00
RenovoRx (RNXT) United States $0.051B 0.00
INmune Bio (INMB) United States $0.050B 0.00
Inovio Pharmaceuticals (INO) United States $0.050B 0.00
Kalaris Therapeutics (KLRS) United States $0.049B 0.00
Renovaro (RENB) United States $0.048B 0.00
Grace Therapeutics (GRCE) Canada $0.046B 0.00
Exicure (XCUR) United States $0.044B 0.00
Rani Therapeutics Holdings (RANI) United States $0.044B 0.00
Scilex Holding (SCLX) United States $0.044B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Mersana Therapeutics (MRSN) United States $0.043B 0.00
Medicus Pharma (MDCX) United States $0.042B 0.00
PepGen (PEPG) United States $0.042B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.041B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Pluri (PLUR) Israel $0.040B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.039B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Cognition Therapeutics (CGTX) United States $0.038B 0.00
KALA BIO (KALA) United States $0.037B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.036B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
CalciMedica (CALC) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Clene (CLNN) United States $0.031B 0.00
Femasys (FEMY) United States $0.031B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.030B 0.00
Generation Bio (GBIO) United States $0.030B 0.00
Dyadic (DYAI) United States $0.029B 0.00
Ovid Therapeutics (OVID) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.027B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
SAB Biotherapeutics (SABS) United States $0.025B 0.00
Q32 Bio (QTTB) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Longeveron (LGVN) United States $0.021B 0.00
Passage Bio (PASG) United States $0.021B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.021B 0.00
Cingulate (CING) United States $0.020B 0.00
Curis (CRIS) United States $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Rallybio (RLYB) United States $0.017B 0.00
Advanced Biomed (ADVB) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Synaptogenix (TAOX) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
Beyond Air (XAIR) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Abpro Holdings (ABP) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Artelo Biosciences (ARTL) United States $0.010B 0.00
GENPREX (GNPX) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Imunon (IMNN) United States $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.009B 0.00
X4 Pharmaceuticals (XFOR) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Purple Biotech (PPBT) Israel $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00